EXHIBIT 23.2
Published on May 19, 2026
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated March 4, 2026 relating to the financial statements of Cellectar Biosciences, Inc., appearing in the Annual Report on Form 10-K of Cellectar Biosciences, Inc. for the year ended December 31, 2025. We also consent to the reference to us under the heading "Experts" in such Registration Statement.
/s/ Deloitte & Touche LLP
Morristown, New Jersey
May 19, 2026